ANAC

Anacor Pharmaceuticals, Inc. Press Releases

$37.05
*  
0.26
0.71%
Get ANAC Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading ANAC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ANAC After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Symbiota Names Entrepreneurial Leader David P. Perry as President and CEO
1/7/2015 9:04:00 AM - PR Newswire
▲18.56 % Price Change since this news event. The Volume Ratio is 1.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Anacor Pharmaceuticals to Present at the 2014 Credit Suisse Healthcare Conference
11/7/2014 4:36:00 PM - Business Wire
▲29.55 % Price Change since this news event. The Volume Ratio is 1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Anacor Pharmaceuticals Reports Third Quarter 2014 Financial Results
11/6/2014 4:01:00 PM - Business Wire
▲27.01 % Price Change since this news event. The Volume Ratio is 0.62.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day